<SEC-DOCUMENT>0001104659-18-065109-index.html : 20181031 <SEC-HEADER>0001104659-18-065109.hdr.sgml : 20181031 <ACCEPTANCE-DATETIME>20181031164857 ACCESSION NUMBER: 0001104659-18-065109 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20181031 DATE AS OF CHANGE: 20181031 EFFECTIVENESS DATE: 20181031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-228094 FILM NUMBER: 181150942 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>a18-38191_1s8.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: a18-38191_1s8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>a18-38191_1ex5d1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: a18-38191_1ex5d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>3 <FILENAME>a18-38191_1ex23d2.htm <DESCRIPTION>EX-23.2 <TEXT> Document 3 - file: a18-38191_1ex23d2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.3 <SEQUENCE>4 <FILENAME>a18-38191_1ex23d3.htm <DESCRIPTION>EX-23.3 <TEXT> Document 4 - file: a18-38191_1ex23d3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.4 <SEQUENCE>5 <FILENAME>a18-38191_1ex23d4.htm <DESCRIPTION>EX-23.4 <TEXT> Document 5 - file: a18-38191_1ex23d4.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g381911kgi001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g381911kgi001.jpg
</DOCUMENT> </SEC-DOCUMENT>